How would you manage a patient with PSA persistence after RALP demonstrating metastasis in regional lymph nodes without further evidence of disease on bone or CT scans?

Community
Company
News
Contact Us
Sign in

Topics: Radiation Oncology • Genitourinary Cancers • Urologic Oncology

Does performance status, age, or urinary incontinence after surgery affect your recommendations?

Related Questions

Is it appropriate to offer definitive trimodality therapy, as an equivalent option to neoadjuvant chemotherapy followed by radical cystectomy, in patients with muscle-invasive bladder cancer regardless of fitness or platinum eligibility?

Is there evidence that prostatectomy improves overall survival in local recurrence of prostate cancer post-definitive radiation?

In a patient with very high risk prostate cancer opting for prostatectomy, when, if ever, do you recommend neoadjuvant ADT?

How do you manage favorable intermediate risk prostate cancer patients that have a PIRADS 5 lesion that was most-likely missed in the template biopsy?

Which patients do you consider to be good candidates for salvage local treatment after radiation therapy?

Do you still order mpMRI for staging of prostate cancer in addition to PET-PSMA?

Would you recommend different fiducial markers for the right/left of a prostate for SBRT?

How would you treat high risk prostate cancer in a patient with autonomic bladder dysfunction?

Would you consider maintenance immunotherapy after cisplatin-gemcitabine chemotherapy and chemoRT for stage 3 bladder cancer in a patient declining cystectomy or who is a poor surgical candidate?

After the results of RTOG 0232, would you be comfortable treating unfavorable intermediate risk prostate cancer with brachytherapy monotherapy?